1. Guest Editorial: DIA/HESI/SAPS Conference on Environmental Risk Assessment of Human Medicines (Stockholm, May 22–23, 2006)

   • Mark Montforts
   • Per Spindler
   • Rich Williams

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 129 - 131

2. Exposure to Pharmaceuticals Present in the Environment

   • Richard T. Williams
   • Jon C. Cook

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 133 - 141

3. Environmental Effects of Human Pharmaceuticals

   • John Phillip Sumpter

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 143 - 147

4. Environmental Assessment for Human Medicines in the European Union

   • Per Spindler
   • Mark Montforts
   • Jan-Willem van der Laan

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 149 - 153

5. Environmental Assessment of Human Pharmaceuticals in the United States of America

   • Keith Webber
   • Per Spindler

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 155 - 157

6. Environmental Assessment of Pharmaceuticals in Canada: A Regulatory Perspective

   • Andrew Beck

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 159 - 162

7. Regulations and Guidelines on Human Health Products in Japan

   • Yoshitada Yoshioka

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 163 - 167

8. Assessing Environmental Impacts of Veterinary Products: Lessons from VICH

   • Joseph A. Robinson

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 169 - 185

9. A Voluntary Environmental Classification System for Pharmaceutical Substances

   • Bengt Mattson

   DIA/HESI/SAPS/Conference 30 December 2007 Pages: 187 - 191

10. Summary of Workshop on Fate of Pharmaceuticals in the Environment

    • Klaus Kümmerer
    • Virginia L. Cunningham

    DIA/HESI/SAPS/Conference 30 December 2007 Pages: 193 - 194

11. Workshop on the Use of Modeling and Monitoring in the Environmental Risk Assessment of Human Medicines

    • Richard Murray-Smith
    • Maria Ramil

    DIA/HESI/SAPS/Conference 30 December 2007 Pages: 195 - 199

12. Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses

    • Klaus Olejniczak
    • Richard T. Williams
    • Per Spindler

    DIA/HESI/SAPS/Conference 30 December 2007 Pages: 201 - 202

13. Summary of Workshop on Environmental Assessment of Human Medicines: Development and Use of Aquatic Toxicity Data

    • Mark H. M. M. Montforts
    • Ingvar Brandt
    • Thomas H. Hutchinson

    DIA/HESI/SAPS/Conference 30 December 2007 Pages: 203 - 209

14. Summary of Workshop on Mixtures

    • Reinhard Laenge
    • Henry Stemplewski

    DIA/HESI/SAPS/Conference 30 December 2007 Pages: 211 - 212

15. Development, Implementation, and Validation of a Capacity Management System

    • Martin D. Hynes III
    • Robert D. Swarts
    • Jeanette M. Colonna

    Regulatory 30 December 2007 Pages: 213 - 220

16. EWOC 2.0: Interactive Software for Dose Escalation in Cancer Phase I Clinical Trials

    • Zhiheng Xu
    • Mourad Tighiouart
    • André Rogatko

    Medical Information 30 December 2007 Pages: 221 - 228

17. Pharmaceutical Manufacturing Efficiency, Drug Prices, and Public Health: Examining the Causal Links

    • John A. Vernon
    • W. Keener Hughen
    • Antonio J. Trujillo

    Medical Information 30 December 2007 Pages: 229 - 239

18. An Assessment of Preparation Methods and Personnel Requirements in a Medical Information Department during Product Launch

    • Tiffany Donald
    • Christi Marsh
    • Laurel Ashworth

    Medical Information 30 December 2007 Pages: 241 - 250

19. Clinical Research Nurses: Roles and Qualifications in South Korea

    • Ihnsook Jeong
    • Hyun-Sook Kang
    • Won-Ock Kim

    Medical Information 30 December 2007 Pages: 251 - 256

20. Can Medicare Draw Lessons from Dutch Experience with a National Formulary?

    • Joshua Cohen
    • Cherie Paquette
    • Catherine Cairns

    Medical Information 30 December 2007 Pages: 257 - 272

21. 2007 EuroMeeting Student Poster Abstracts

    Abstracts 30 December 2007 Pages: 273 - 280